Benjamin M Kagina - JoVE Visualize

Showing results (31-40 of 39) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 39 results.

Ebiomedicine|March 11, 2026

Lack of harmonisation in immunological data: challenges in synthesising data during the COVID-19 pandemicNicole Shaver, Caroline Colijn, Jane Heffernan, et al.

Clinical and Vaccine Immunology : CVI|May 1, 2015

Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T CellsNicole Lenz, Tobias Schindler, Benjamin M Kagina, et al.

Vaccine|November 22, 2016

H1:IC31 vaccination is safe and induces long-lived TNF-α+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trialHelen Mearns, Hennie D Geldenhuys, Benjamin M Kagina, et al.

Vaccine|October 23, 2023

Conference report: WHO meeting summary on mRNA-based tuberculosis vaccine developmentMonika M Looney, Mark Hatherill, Munyaradzi Musvosvi, et al.

Journal of Immunological Methods|December 20, 2014

Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometryBenjamin M Kagina, Nazma Mansoor, Eloi P Kpamegan, et al.

BMC Medicine|May 18, 2016

Human newborn bacille Calmette-Guérin vaccination and risk of tuberculosis disease: a case-control studyHelen A Fletcher, Ali Filali-Mouhim, Elisa Nemes, et al.

Plos One|December 10, 2014

Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trialKlaus Reither, Lynn Katsoulis, Trevor Beattie, et al.

Vaccines|May 26, 2026

Accelerating Evidence-Informed Vaccine Introductions: Lessons from the Hexavalent Early Adopters WorkshopKathryn L Hopkins, Sidy Ndiaye, Zeinebou Sidi Abdullah, et al.

Vaccine|September 17, 2023

Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectivenessNicole Shaver, Melanie Katz, Gideon Darko Asamoah, et al.

Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 39 results.

Ebiomedicine|March 11, 2026

Lack of harmonisation in immunological data: challenges in synthesising data during the COVID-19 pandemicNicole Shaver, Caroline Colijn, Jane Heffernan, et al.

Clinical and Vaccine Immunology : CVI|May 1, 2015

Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T CellsNicole Lenz, Tobias Schindler, Benjamin M Kagina, et al.

Vaccine|November 22, 2016

H1:IC31 vaccination is safe and induces long-lived TNF-α+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trialHelen Mearns, Hennie D Geldenhuys, Benjamin M Kagina, et al.

Vaccine|October 23, 2023

Conference report: WHO meeting summary on mRNA-based tuberculosis vaccine developmentMonika M Looney, Mark Hatherill, Munyaradzi Musvosvi, et al.

Journal of Immunological Methods|December 20, 2014

Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometryBenjamin M Kagina, Nazma Mansoor, Eloi P Kpamegan, et al.

BMC Medicine|May 18, 2016

Human newborn bacille Calmette-Guérin vaccination and risk of tuberculosis disease: a case-control studyHelen A Fletcher, Ali Filali-Mouhim, Elisa Nemes, et al.

Plos One|December 10, 2014

Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trialKlaus Reither, Lynn Katsoulis, Trevor Beattie, et al.

Vaccines|May 26, 2026

Accelerating Evidence-Informed Vaccine Introductions: Lessons from the Hexavalent Early Adopters WorkshopKathryn L Hopkins, Sidy Ndiaye, Zeinebou Sidi Abdullah, et al.

Vaccine|September 17, 2023

Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectivenessNicole Shaver, Melanie Katz, Gideon Darko Asamoah, et al.

Pageof 4